Wim Verheyden: Difference between revisions
Appearance
No edit summary |
m Sulfurboy moved page Draft:Wim Verheyden to Wim Verheyden: Publishing accepted Articles for creation submission (AFCH 0.9.1) |
(No difference)
|
Revision as of 11:37, 12 March 2021
This article, Wim Verheyden, has recently been created via the Articles for creation process. Please check to see if the reviewer has accidentally left this template after accepting the draft and take appropriate action as necessary.
Reviewer tools: Inform author |
- Comment: There should be more sources as the person is notable per WP:NPOL. Feel free to ping me directly on my talk page to ask for a re-review. Eyebeller 17:28, 11 January 2021 (UTC)
Wim Verheyden (born Bornem, May 9, 1967) is a Belgian-Flemish politician who has been a member of the Flemish Parliament since 2019 for the Vlaams Belang party.
Verheyden worked for the pharmaceuticals company Pfizer. He became politically active for the Vlaams Belang and has been a municipal councilor of Bornem for VB since 2007.[1] He was also provincial councilor of Antwerp from 2018 to 2019. In the elections of May 26, 2019, Verheyden was elected to the Flemish Parliament for the Antwerp constituency.[2][3][4][5]
References
- ^ Wim Verheyden verkozen voor het Vlaams Parlement, Het Laatste Nieuws, 27 mei 2019.
- ^ Parlement, Vlaams. "Wim Verheyden (Vlaams Belang)". www.vlaamsparlement.be.
- ^ https://www.rtv.be/artikels/wim-verheyden-vlaams-belang-afgelopen-jaar-was-grote-roetsjbaan-a68996
- ^ https://vlaamsparlement.tv/nieuwe-leeuwenwim-verheyden-vlaams-belang/
- ^ https://vrttaal.net/taaladvies-spelling/vlaamse-volksvertegenwoordigers
Category:Living people Category:Vlaams Belang politicians Category:Flemish politicians Category:Members of the Flemish Parliament Category:1967 births Category:People from Bornem
This article, Wim Verheyden, has recently been created via the Articles for creation process. Please check to see if the reviewer has accidentally left this template after accepting the draft and take appropriate action as necessary.
Reviewer tools: Inform author |